Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma
Clinical trial NCT03398122 · UNKNOWN
Trial details
- NCT number
- NCT03398122
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2018-10-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.